Stocks Comparison
HeartSciences vs SkyAI: revenue, profit, margins and growth compared
HeartSciences brought in $4.3K of revenue in fiscal 2026, SkyAI $204.1K in fiscal 2025. HeartSciences kept -211,666.5% of its revenue as net profit, SkyAI -138,400.0%.
Side by side, latest fiscal year
| HSCS | SKYA | |
|---|---|---|
| Fiscal year ended | FY2026 (April 30, 2026) | FY2025 (December 31, 2025) |
| Revenue | $4.3K | $204.1K |
| Revenue growth | -0.7% | n/a |
| Net income | -$9.1M | -$282.5M |
| Net margin | -211,666.5% | -138,400.0% |
| Free cash flow | -$7.4M | n/a |
| Free cash flow margin | -172,036.6% | n/a |
| Earnings per share (diluted) | -$3.48 | -$11.16 |
| Cash | $1.7M | $10.4M |
| Debt | n/a | n/a |
| Price to earnings | n/a | n/a |
| Market value | $18.4M | $80.8M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #646 of 646 · Health care | #609 of 646 · Health care |
Over the years
HSCS $4.3KSKYA $204.1K
HSCS -$9.1MSKYA -$282.5M
HSCS -211,666.5%SKYA -138,400.0%
HSCS -0.7%SKYA
HSCS -$7.4MSKYA -$4.5M
Questions about HeartSciences and SkyAI
Which is bigger by revenue, HeartSciences or SkyAI?
SkyAI is bigger by revenue: $204.1K in fiscal 2025, against $4.3K for HeartSciences in fiscal 2026.
Which keeps more of its revenue as profit, HeartSciences or SkyAI?
HeartSciences had a net margin of -211,666.5% in fiscal 2026; SkyAI had -138,400.0% in fiscal 2025.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.